The drug Mavorixafor was previously granted the Fast Track designation for the treatment of WHIM syndrome, a rare immunodeficiency indication for which it received FDA approval in April 2024, X4 said.

Welcome to Indie App Spotlight. This is a weekly 9to5Mac series where we showcase the latest apps in the indie ...

Health trackers keep tabs on nearly 1 in 4 Americans at this point. Professor of Medicine Sandeep Kishore, MD, PhD, MSc, ...

The multiple regulatory designations were granted following strong positive results from a global randomized Phase 1b/2 study in first-line HCC demonstrating superior outcomes for amezalpat ...

RTX carries a strong balance sheet with a BBB+ credit rating from S&P. This is supported by $5.2 billion in cash on hand, and ...

Many folks in NC can’t access Ozempic due to limited insurance coverage. But policy changes and falling prices may expand ...

Qure divested for $25M, advanced AMT-130 with FDA approvals, and building infrastructure. A strong balance sheet backs ...

BUENOS AIRES (Reuters) -Argentina's government said on Monday that it will review the use of fast-track authorizations for high cost drugs, as well as requiring future vaccine trials to include a ...

In the final years of Elvis Presley’s life, those close to him began to worry about his use of drugs. His declining health even appeared apparent to those who only knew him as a public figure ...

A career crook Mayor Adams once dubbed “Recidivist No. 1” and the symbol of NYC’s revolving-door justice system is still circling back on crime — his staggering rap sheet is now 134 ...

President Donald Trump said his executive order on drug prices would lower some prices in half or more. But the details are ...